Healthcare innovation to double at $60 bn opportunity by FY28 in India
Healthcare innovation in India, currently valued at $30 billion, is expected to double by FY28, according to a recent report by Bain & Company and...
Tag : pharma news
In a Phase 4 clinical trial, Sun Pharma’s ophthalmic medication has exhibited encouraging results.
CEQUA was generally well tolerated in the study, consistent with its established safety profile, and there were no new safety signals in the trial, it...